永创医药 (833453.oc)

+ 收藏

财务分析(报告期)(永创医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 159,146,483.14302,500,522.78250,132,611.59194,167,020.43111,279,078.19277,785,676.44219,978,457.48147,611,576.56-
 营业利润(元) 45,498,135.8364,406,282.5557,400,093.1047,200,903.4523,125,316.0562,270,584.1453,973,350.3633,266,083.94-
 利润总额(元) 45,497,979.1764,392,809.9357,362,220.4247,195,030.7723,125,316.0562,068,418.6953,727,689.9833,024,497.16-
 净利润(元) 39,305,520.0856,124,331.5749,712,221.2040,722,248.6919,893,057.9854,050,787.0438,546,275.1422,836,441.49-
 归属于母公司股东的净利润(元) 39,305,520.0856,124,331.5749,712,221.2040,722,248.6919,893,057.9854,050,787.0438,546,275.1422,836,441.49-
盈利能力:
 销售毛利率(%) 35.2427.1127.5528.1324.4029.0229.4627.2727.15
 销售净利率(%) 24.7018.5519.8720.9717.2719.4620.3818.6318.21
 净资产收益率(%) 22.2739.7137.3833.66-----
 总资产报酬率ROA(%) 19.7730.4931.4124.59-----
 投入资本回报率ROIC(%) 21.3039.6135.4430.4715.0050.7042.6328.5530.37
营运能力:
 存货周转率(次) 1.513.513.392.25-----
 应收账款周转率(次) 6.2119.7012.8112.31-----
 总资产周转率(次) 0.691.491.431.07-----
偿债能力:
 资产负债率(%) 13.7716.2917.8333.3044.0643.6631.2233.92-
 股东权益比率(%) 86.2383.7182.1766.7055.9456.3468.7866.08-
 已获利息倍数(倍) -852.07-25.33-22.12-18.29-10.48256.81-256.47-112.65-
 流动比率 5.604.404.162.331.811.742.182.01-
 速动比率 3.552.292.081.311.201.041.170.95-
发展能力:
 营业收入增长率(%) -18.048.9011.9528.5340.9956.4291.41104.24-
 营业利润增长率(%) -3.613.439.3245.0435.1231.02121.0293.45-
 税后利润增长率(%) -3.483.849.1744.6633.7044.22145.8287.23-
 净资产增长率(%) 37.7939.0244.3160.94-39.81-35.79-
 总资产增长率(%) 6.59-6.437.7930.24-38.62-49.03-

前瞻产业研究院